395 related articles for article (PubMed ID: 36154585)
1. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
Sa P; Sahoo SK; Dilnawaz F
Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
[TBL] [Abstract][Full Text] [Related]
2. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.
Chen S; Yang K; Tuguntaev RG; Mozhi A; Zhang J; Wang PC; Liang XJ
Nanomedicine; 2016 Feb; 12(2):269-86. PubMed ID: 26707818
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.
Cao Y; Meng F; Cai T; Gao L; Lee J; Solomevich SO; Aharodnikau UE; Guo T; Lan M; Liu F; Li Q; Viktor T; Li D; Cai Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1950. PubMed ID: 38528388
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities.
Nezhadi S; Saadat E; Handali S; Dorkoosh F
J Drug Target; 2021 Feb; 29(2):185-198. PubMed ID: 32772739
[TBL] [Abstract][Full Text] [Related]
7. Anticancer nanomedicines harnessing tumor microenvironmental components.
Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
[TBL] [Abstract][Full Text] [Related]
8. Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy.
Jha A; Kumar M; Bharti K; Manjit M; Mishra B
Nanomedicine (Lond); 2024 Mar; 19(7):633-651. PubMed ID: 38445583
[TBL] [Abstract][Full Text] [Related]
9. Physical oncology: New targets for nanomedicine.
Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
[TBL] [Abstract][Full Text] [Related]
10. Tumor Microenvironment-Enabled Nanotherapy.
Wang L; Huo M; Chen Y; Shi J
Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
[TBL] [Abstract][Full Text] [Related]
11. Nanotherapy Targeting the Tumor Microenvironment.
Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
13. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
Sia CS; Lim HP; Tey BT; Goh BH; Low LE
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
[TBL] [Abstract][Full Text] [Related]
14. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
15. Remodeling tumor microenvironment with nanomedicines.
Martin JD; Miyazaki T; Cabral H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment and nanotherapeutics: intruding the tumor fort.
Ravi Kiran AVVV; Kusuma Kumari G; Krishnamurthy PT; Khaydarov RR
Biomater Sci; 2021 Nov; 9(23):7667-7704. PubMed ID: 34673853
[TBL] [Abstract][Full Text] [Related]
17. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous nanodrug delivery system: a powerful tool for a new paradigm of remodeling of the tumor microenvironment.
Hang Y; Liu Y; Teng Z; Cao X; Zhu H
J Nanobiotechnology; 2023 Mar; 21(1):101. PubMed ID: 36945005
[TBL] [Abstract][Full Text] [Related]
19. From Passive Targeting to Personalized Nanomedicine: Multidimensional Insights on Nanoparticles' Interaction with the Tumor Microenvironment.
Sebak AA; El-Shenawy BM; El-Safy S; El-Shazly M
Curr Pharm Biotechnol; 2021; 22(11):1444-1465. PubMed ID: 33308126
[TBL] [Abstract][Full Text] [Related]
20. The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy.
Liu S; Khan AR; Yang X; Dong B; Ji J; Zhai G
J Control Release; 2021 Jul; 335():1-20. PubMed ID: 33991600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]